These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19961476)

  • 1. The toxicokinetics and toxicodynamics of organophosphonates versus the pharmacokinetics and pharmacodynamics of oxime antidotes: biological consequences.
    Voicu VA; Thiermann H; Rădulescu FS; Mircioiu C; Miron DS
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):73-85. PubMed ID: 19961476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of some oximes and associated therapeutic consequences: a critical review.
    Voicu VA; Bajgar J; Medvedovici A; Radulescu FS; Miron DS
    J Appl Toxicol; 2010 Nov; 30(8):719-29. PubMed ID: 20635332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems.
    Voicu V; Rădulescu FŞ; Medvedovici A
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):95-109. PubMed ID: 25373357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents.
    Bajgar J; Kuca K; Jun D; Bartosova L; Fusek J
    Curr Drug Metab; 2007 Dec; 8(8):803-9. PubMed ID: 18220560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quaternary and tertiary aldoxime antidotes for organophosphate exposure in a zebrafish model system.
    Schmidt HR; Radić Z; Taylor P; Fradinger EA
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):197-203. PubMed ID: 25701203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.
    Thompson CM; Gerdes JM; VanBrocklin HF
    Neurobiol Dis; 2020 Jan; 133():104455. PubMed ID: 31022458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds.
    Su CT; Wang PH; Liu RF; Shih JH; Ma C; Lin CH; Liu CY; Wu MT
    Fundam Appl Toxicol; 1986 Apr; 6(3):506-14. PubMed ID: 3699334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors.
    Soukup O; Jun D; Tobin G; Kuca K
    Arch Toxicol; 2013 Apr; 87(4):711-9. PubMed ID: 23179755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
    Worek F; Szinicz L; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo oxime administration does not influence Ellman acetylcholinesterase assay results.
    Guarisco JA; O'Donnell JC; Skovira JW; McDonough JH; Shih TM
    Toxicol Mech Methods; 2009 Sep; 19(6-7):379-85. PubMed ID: 19778238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
    Soukup O; Korabecny J; Malinak D; Nepovimova E; Pham NL; Musilek K; Hrabinova M; Hepnarova V; Dolezal R; Pavek P; Jost P; Kobrlova T; Jankockova J; Gorecki L; Psotka M; Nguyen TD; Box K; Outhwaite B; Ceckova M; Sorf A; Jun D; Kuca K
    Med Chem; 2018; 14(3):281-292. PubMed ID: 29332594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
    Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.